Published in Blood Weekly, January 29th, 2004
Oncologists in the United States "performed a multivariable comparison of 125 consecutive patients with follicular lymphoma (FL) treated at our centers with either high-dose radioimmunotherapy (HD-RIT) using I-131-anti-CD20 (n=27) or conventional high-dose therapy (C-HDT) (n=98) and autologous hematopoietic stem-cell transplantation."
"The groups were similar, although more patients treated with HD-RIT had an elevated pretransplantation level of lactate dehydrogenase (41% versus 20%, p=0.03) and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.